Louise Wideroff
Louise Wideroff, PhD, is a Program Director in the Risk Factor Monitoring and Methods
Branch of the Applied Research Program. Her areas of expertise include assessment and use
of family history of cancer information, and clinical utility of emerging cellular,
molecular, and genomic technologies for cancer prevention, early detection, diagnosis, and
treatment. She currently serves as program director for the R01 and R21 Program
Announcements entitled "Understanding the Effects of Emerging Cellular, Molecular, and
Genomic Technologies in Cancer Care". She has also served as NCI Project Officer on
research contracts addressing family history of cancer accuracy and interpretability,
physician use of genetic tests for inherited breast/ovarian and colorectal cancer
susceptibility, and cancer risk associated with blood transfusions from cancer
survivors.
Dr. Wideroff received her PhD in Epidemiology from the University of Michigan, and her
MSPH in Epidemiology from the University of Illinois. Prior to joining the Applied
Research Program in 1997, she completed a post-doctoral fellowship in cancer epidemiology
in the Division of Cancer Epidemiology and Genetics at NCI. Her doctoral and post-doctoral
research focused on human papillomavirus infection and humoral immune response in
urogential cancers. During this time, she received laboratory training in nucleic acid and
antibody detection methods. Her interests include molecular and modifiable risk factors
for cancer progression, and effectiveness of and access to molecular diagnostic tools and
targeted therapies in routine clinical care.
|
